+1 347 708 0418
The Peripheral Intervention Drug-Eluting Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Peripheral Intervention Drug-Eluting Devices size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Peripheral Intervention Drug-Eluting Devices market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Peripheral Intervention Drug-Eluting Devices market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Drug-Eluting Balloons
Drug-Eluting Stents
Market segment by Application can be divided into
Plain Old Balloon Angioplasty (POBA)
Percutaneous Transluminal Angioplasty (PTA)
The key market players for global Peripheral Intervention Drug-Eluting Devices market are listed below:
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
Cardinal Health
B. Braun Melsungen AG
Biosensors International Group Ltd.
C.R. Bard, Inc.
Abbott
The Lubrizol Corporation
Terumo Corporation
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Peripheral Intervention Drug-Eluting Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Peripheral Intervention Drug-Eluting Devices, with price, sales, revenue and global market share of Peripheral Intervention Drug-Eluting Devices from 2019 to 2021.
Chapter 3, the Peripheral Intervention Drug-Eluting Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Peripheral Intervention Drug-Eluting Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Peripheral Intervention Drug-Eluting Devices market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Peripheral Intervention Drug-Eluting Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Peripheral Intervention Drug-Eluting Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Peripheral Intervention Drug-Eluting Devices Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Drug-Eluting Balloons
1.2.3 Drug-Eluting Stents
1.3 Market Analysis by Application
1.3.1 Overview: Global Peripheral Intervention Drug-Eluting Devices Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Plain Old Balloon Angioplasty (POBA)
1.3.3 Percutaneous Transluminal Angioplasty (PTA)
1.4 Global Peripheral Intervention Drug-Eluting Devices Market Size & Forecast
1.4.1 Global Peripheral Intervention Drug-Eluting Devices Sales in Value (2016-2026))
1.4.2 Global Peripheral Intervention Drug-Eluting Devices Sales in Volume (2016-2026)
1.4.3 Global Peripheral Intervention Drug-Eluting Devices Price by Type (2016-2026) & (USD/Unit)
1.5 Global Peripheral Intervention Drug-Eluting Devices Production Capacity Analysis
1.5.1 Global Peripheral Intervention Drug-Eluting Devices Total Production Capacity (2016-2026)
1.5.2 Global Peripheral Intervention Drug-Eluting Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Peripheral Intervention Drug-Eluting Devices Market Drivers
1.6.2 Peripheral Intervention Drug-Eluting Devices Market Restraints
1.6.3 Peripheral Intervention Drug-Eluting Devices Trends Analysis
2 Manufacturers Profiles
2.1 Medtronic plc
2.1.1 Medtronic plc Details
2.1.2 Medtronic plc Major Business
2.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Product and Services
2.1.4 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Boston Scientific Corporation
2.2.1 Boston Scientific Corporation Details
2.2.2 Boston Scientific Corporation Major Business
2.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product and Services
2.2.4 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product and Services
2.3.4 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Cardinal Health
2.4.1 Cardinal Health Details
2.4.2 Cardinal Health Major Business
2.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Product and Services
2.4.4 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 B. Braun Melsungen AG
2.5.1 B. Braun Melsungen AG Details
2.5.2 B. Braun Melsungen AG Major Business
2.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product and Services
2.5.4 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Biosensors International Group Ltd.
2.6.1 Biosensors International Group Ltd. Details
2.6.2 Biosensors International Group Ltd. Major Business
2.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product and Services
2.6.4 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 C.R. Bard, Inc.
2.7.1 C.R. Bard, Inc. Details
2.7.2 C.R. Bard, Inc. Major Business
2.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product and Services
2.7.4 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Abbott
2.8.1 Abbott Details
2.8.2 Abbott Major Business
2.8.3 Abbott Peripheral Intervention Drug-Eluting Devices Product and Services
2.8.4 Abbott Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 The Lubrizol Corporation
2.9.1 The Lubrizol Corporation Details
2.9.2 The Lubrizol Corporation Major Business
2.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product and Services
2.9.4 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Terumo Corporation
2.10.1 Terumo Corporation Details
2.10.2 Terumo Corporation Major Business
2.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product and Services
2.10.4 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Peripheral Intervention Drug-Eluting Devices Sales by Manufacturer
3.1 Global Peripheral Intervention Drug-Eluting Devices Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Peripheral Intervention Drug-Eluting Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Peripheral Intervention Drug-Eluting Devices Manufacturer Market Share
3.4.2 Top 6 Peripheral Intervention Drug-Eluting Devices Manufacturer Market Share
3.5 Global Peripheral Intervention Drug-Eluting Devices Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Peripheral Intervention Drug-Eluting Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Peripheral Intervention Drug-Eluting Devices Market Size by Region
4.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales in Volume by Region (2016-2026)
4.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Region (2016-2026)
4.2 North America Peripheral Intervention Drug-Eluting Devices Revenue (2016-2026)
4.3 Europe Peripheral Intervention Drug-Eluting Devices Revenue (2016-2026)
4.4 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue (2016-2026)
4.5 South America Peripheral Intervention Drug-Eluting Devices Revenue (2016-2026)
4.6 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Peripheral Intervention Drug-Eluting Devices Sales in Volume by Type (2016-2026)
5.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2016-2026)
5.3 Global Peripheral Intervention Drug-Eluting Devices Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Peripheral Intervention Drug-Eluting Devices Sales in Volume by Application (2016-2026)
6.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Application (2016-2026)
6.3 Global Peripheral Intervention Drug-Eluting Devices Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2026)
7.2 North America Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2026)
7.3 North America Peripheral Intervention Drug-Eluting Devices Market Size by Country
7.3.1 North America Peripheral Intervention Drug-Eluting Devices Sales in Volume by Country (2016-2026)
7.3.2 North America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2026)
8.2 Europe Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2026)
8.3 Europe Peripheral Intervention Drug-Eluting Devices Market Size by Country
8.3.1 Europe Peripheral Intervention Drug-Eluting Devices Sales in Volume by Country (2016-2026)
8.3.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2026)
9.2 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2026)
9.3 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market Size by Region
9.3.1 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2026)
10.2 South America Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2026)
10.3 South America Peripheral Intervention Drug-Eluting Devices Market Size by Country
10.3.1 South America Peripheral Intervention Drug-Eluting Devices Sales in Volume by Country (2016-2026)
10.3.2 South America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2026)
11.2 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2026)
11.3 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Market Size by Country
11.3.1 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Peripheral Intervention Drug-Eluting Devices Typical Distributors
12.3 Peripheral Intervention Drug-Eluting Devices Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Peripheral Intervention Drug-Eluting Devices Revenue by Type, (USD Million), 2021-2026
Table 2. Global Peripheral Intervention Drug-Eluting Devices Revenue by Application, (USD Million), 2021-2026
Table 3. Medtronic plc Basic Information, Manufacturing Base and Competitors
Table 4. Medtronic plc Major Business
Table 5. Medtronic plc Peripheral Intervention Drug-Eluting Devices Product and Services
Table 6. Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 8. Boston Scientific Corporation Major Business
Table 9. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product and Services
Table 10. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 12. Abbott Laboratories Major Business
Table 13. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product and Services
Table 14. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 16. Cardinal Health Major Business
Table 17. Cardinal Health Peripheral Intervention Drug-Eluting Devices Product and Services
Table 18. Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. B. Braun Melsungen AG Basic Information, Manufacturing Base and Competitors
Table 20. B. Braun Melsungen AG Major Business
Table 21. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product and Services
Table 22. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Biosensors International Group Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Biosensors International Group Ltd. Major Business
Table 25. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product and Services
Table 26. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. C.R. Bard, Inc. Basic Information, Manufacturing Base and Competitors
Table 28. C.R. Bard, Inc. Major Business
Table 29. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product and Services
Table 30. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Abbott Basic Information, Manufacturing Base and Competitors
Table 32. Abbott Major Business
Table 33. Abbott Peripheral Intervention Drug-Eluting Devices Product and Services
Table 34. Abbott Peripheral Intervention Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. The Lubrizol Corporation Basic Information, Manufacturing Base and Competitors
Table 36. The Lubrizol Corporation Major Business
Table 37. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product and Services
Table 38. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Terumo Corporation Basic Information, Manufacturing Base and Competitors
Table 40. Terumo Corporation Major Business
Table 41. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product and Services
Table 42. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Peripheral Intervention Drug-Eluting Devices Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Peripheral Intervention Drug-Eluting Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Peripheral Intervention Drug-Eluting Devices Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Peripheral Intervention Drug-Eluting Devices Production Site of Key Manufacturer
Table 48. Peripheral Intervention Drug-Eluting Devices New Entrant and Capacity Expansion Plans
Table 49. Peripheral Intervention Drug-Eluting Devices Mergers & Acquisitions in the Past Five Years
Table 50. Global Peripheral Intervention Drug-Eluting Devices Sales by Region (2016-2021e) & (K Units)
Table 51. Global Peripheral Intervention Drug-Eluting Devices Sales by Region (2021-2026) & (K Units)
Table 52. Global Peripheral Intervention Drug-Eluting Devices Revenue by Region (2016-2021e) & (USD Million)
Table 53. Global Peripheral Intervention Drug-Eluting Devices Revenue by Region (2021-2026) & (USD Million)
Table 54. Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units)
Table 55. Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2021-2026) & (K Units)
Table 56. Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2016-2021e) & (USD Million)
Table 57. Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2021-2026) & (USD Million)
Table 58. Global Peripheral Intervention Drug-Eluting Devices Price by Type (2016-2021e) & (USD/Unit)
Table 59. Global Peripheral Intervention Drug-Eluting Devices Price by Type (2021-2026) & (USD/Unit)
Table 60. Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units)
Table 61. Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2021-2026) & (K Units)
Table 62. Global Peripheral Intervention Drug-Eluting Devices Revenue by Application (2016-2021e) & (USD Million)
Table 63. Global Peripheral Intervention Drug-Eluting Devices Revenue by Application (2021-2026) & (USD Million)
Table 64. Global Peripheral Intervention Drug-Eluting Devices Price by Application (2016-2021e) & (USD/Unit)
Table 65. Global Peripheral Intervention Drug-Eluting Devices Price by Application (2021-2026) & (USD/Unit)
Table 66. North America Peripheral Intervention Drug-Eluting Devices Sales by Country (2016-2021e) & (K Units)
Table 67. North America Peripheral Intervention Drug-Eluting Devices Sales by Country (2021-2026) & (K Units)
Table 68. North America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2021e) & (USD Million)
Table 69. North America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2021-2026) & (USD Million)
Table 70. North America Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units)
Table 71. North America Peripheral Intervention Drug-Eluting Devices Sales by Type (2021-2026) & (K Units)
Table 72. North America Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units)
Table 73. North America Peripheral Intervention Drug-Eluting Devices Sales by Application (2021-2026) & (K Units)
Table 74. Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2016-2021e) & (K Units)
Table 75. Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2021-2026) & (K Units)
Table 76. Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2021e) & (USD Million)
Table 77. Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2021-2026) & (USD Million)
Table 78. Europe Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units)
Table 79. Europe Peripheral Intervention Drug-Eluting Devices Sales by Type (2021-2026) & (K Units)
Table 80. Europe Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units)
Table 81. Europe Peripheral Intervention Drug-Eluting Devices Sales by Application (2021-2026) & (K Units)
Table 82. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales by Region (2016-2021e) & (K Units)
Table 83. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales by Region (2021-2026) & (K Units)
Table 84. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Region (2016-2021e) & (USD Million)
Table 85. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Region (2021-2026) & (USD Million)
Table 86. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units)
Table 87. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales by Type (2021-2026) & (K Units)
Table 88. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units)
Table 89. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales by Application (2021-2026) & (K Units)
Table 90. South America Peripheral Intervention Drug-Eluting Devices Sales by Country (2016-2021e) & (K Units)
Table 91. South America Peripheral Intervention Drug-Eluting Devices Sales by Country (2021-2026) & (K Units)
Table 92. South America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2021e) & (USD Million)
Table 93. South America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2021-2026) & (USD Million)
Table 94. South America Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units)
Table 95. South America Peripheral Intervention Drug-Eluting Devices Sales by Type (2021-2026) & (K Units)
Table 96. South America Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units)
Table 97. South America Peripheral Intervention Drug-Eluting Devices Sales by Application (2021-2026) & (K Units)
Table 98. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Country (2016-2021e) & (K Units)
Table 99. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Country (2021-2026) & (K Units)
Table 100. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2021e) & (USD Million)
Table 101. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units)
Table 103. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Type (2021-2026) & (K Units)
Table 104. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units)
Table 105. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Application (2021-2026) & (K Units)
Table 106. Direct Channel Pros & Cons
Table 107. Indirect Channel Pros & Cons
Table 108. Peripheral Intervention Drug-Eluting Devices Typical Distributors
Table 109. Peripheral Intervention Drug-Eluting Devices Typical Customers
List of Figures
Figure 1. Peripheral Intervention Drug-Eluting Devices Picture
Figure 2. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type in 2020
Figure 3. Drug-Eluting Balloons
Figure 4. Drug-Eluting Stents
Figure 5. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application in 2020
Figure 6. Plain Old Balloon Angioplasty (POBA)
Figure 7. Percutaneous Transluminal Angioplasty (PTA)
Figure 8. Global Peripheral Intervention Drug-Eluting Devices Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Peripheral Intervention Drug-Eluting Devices Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Peripheral Intervention Drug-Eluting Devices Sales (2016-2026) & (K Units)
Figure 11. Global Peripheral Intervention Drug-Eluting Devices Price by Type (2016-2026) & (USD/Unit)
Figure 12. Global Peripheral Intervention Drug-Eluting Devices Production Capacity (2016-2026) & (K Units)
Figure 13. Global Peripheral Intervention Drug-Eluting Devices Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Peripheral Intervention Drug-Eluting Devices Market Drivers
Figure 15. Peripheral Intervention Drug-Eluting Devices Market Restraints
Figure 16. Peripheral Intervention Drug-Eluting Devices Market Trends
Figure 17. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Manufacturer in 2020
Figure 18. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Manufacturer in 2020
Figure 19. Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Peripheral Intervention Drug-Eluting Devices Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Peripheral Intervention Drug-Eluting Devices Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2016-2026)
Figure 23. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2016-2026)
Figure 24. North America Peripheral Intervention Drug-Eluting Devices Revenue (2016-2026) & (USD Million)
Figure 25. Europe Peripheral Intervention Drug-Eluting Devices Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue (2016-2026) & (USD Million)
Figure 27. South America Peripheral Intervention Drug-Eluting Devices Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue (2016-2026) & (USD Million)
Figure 29. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2016-2026)
Figure 30. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2016-2026)
Figure 31. Global Peripheral Intervention Drug-Eluting Devices Price by Type (2016-2026) & (USD/Unit)
Figure 32. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2016-2026)
Figure 33. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2016-2026)
Figure 34. Global Peripheral Intervention Drug-Eluting Devices Price by Application (2016-2026) & (USD/Unit)
Figure 35. North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2016-2026)
Figure 36. North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2016-2026)
Figure 37. North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2016-2026)
Figure 38. North America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2016-2026)
Figure 39. United States Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2016-2026)
Figure 43. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2016-2026)
Figure 44. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2016-2026)
Figure 45. Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2016-2026)
Figure 46. Germany Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2016-2026)
Figure 55. China Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2016-2026)
Figure 62. South America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2016-2026)
Figure 63. South America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2016-2026)
Figure 64. South America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
Buy
